Shares of PharMerica Corp. (NYSE:PMC) were down 3.1% on Wednesday . The stock traded as low as $25.00 and last traded at $25.08, with a volume of 137,918 shares. The stock had previously closed at $25.89.

Several analysts have weighed in on PMC shares. TheStreet cut shares of PharMerica Corp. from a “buy” rating to a “hold” rating in a research note on Monday, May 9th. Zacks Investment Research cut shares of PharMerica Corp. from a “hold” rating to a “sell” rating in a research note on Thursday, August 11th. Bank of America Corp. started coverage on shares of PharMerica Corp. in a research note on Tuesday, June 7th. They set a “buy” rating and a $32.00 price objective on the stock. Finally, Barrington Research reaffirmed an “outperform” rating and set a $34.00 price objective (up from $30.00) on shares of PharMerica Corp. in a research note on Tuesday, May 10th. One analyst has rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating to the company. PharMerica Corp. currently has an average rating of “Buy” and an average target price of $31.57.

The company’s 50 day moving average is $25.01 and its 200-day moving average is $24.57. The company has a market cap of $777.10 million and a price-to-earnings ratio of 26.10.

PharMerica Corp. (NYSE:PMC) last issued its earnings results on Tuesday, August 9th. The company reported $0.47 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.47. The company had revenue of $519.60 million for the quarter, compared to the consensus estimate of $508.31 million. During the same period in the prior year, the company earned $0.48 earnings per share. The firm’s revenue was up 4.4% compared to the same quarter last year. Equities analysts anticipate that PharMerica Corp. will post $2.01 EPS for the current fiscal year.

An institutional investor recently raised its position in PharMerica Corp. stock. Wells Fargo & Company MN increased its stake in PharMerica Corp. (NYSE:PMC) by 3.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 305,474 shares of the company’s stock after buying an additional 10,609 shares during the period. Wells Fargo & Company MN owned approximately 1.00% of PharMerica Corp. worth $10,692,000 as of its most recent SEC filing.

PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.